Royal Bank of Canada
TNDM icon

Royal Bank of Canada’s Tandem Diabetes Care TNDM Stock Holding History

Royal Bank of Canada’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.95M Sell
206,033
-2,495
-1% -$54.2K ﹤0.01% 2594
2025
Q4 		$4.58M Sell
208,528
-472,550
-69% -$8.53M ﹤0.01% 2492
2025
Q3 		$8.27M Buy
681,078
+131,536
+24% +$1.78M ﹤0.01% 2278
2025
Q2 		$10.2M Buy
549,542
+337,876
+160% +$6.69M ﹤0.01% 2022
2025
Q1 		$4.05M Buy
211,666
+49,408
+30% +$1.45M ﹤0.01% 2420
2024
Q4 		$5.84M Sell
162,258
-10,594
-6% -$358K ﹤0.01% 2196
2024
Q3 		$7.33M Sell
172,852
-17,856
-9% -$757K ﹤0.01% 1986
2024
Q2 		$7.68M Buy
190,708
+107,386
+129% +$4.48M ﹤0.01% 1851
2024
Q1 		$2.95M Buy
83,322
+14,915
+22% +$400K ﹤0.01% 2610
2023
Q4 		$2.02M Buy
68,407
+37,682
+123% +$782K ﹤0.01% 3070
2023
Q3 		$637K Sell
30,725
-13,314
-30% -$366K ﹤0.01% 3831
2023
Q2 		$1.08M Buy
44,039
+2,471
+6% +$79.5K ﹤0.01% 3311
2023
Q1 		$1.69M Buy
41,568
+8,390
+25% +$347K ﹤0.01% 2925
2022
Q4 		$1.49M Sell
33,178
-13,723
-29% -$621K ﹤0.01% 3159
2022
Q3 		$2.25M Buy
46,901
+27,257
+139% +$1.49M ﹤0.01% 2756
2022
Q2 		$1.16M Sell
19,644
-20,758
-51% -$1.7M ﹤0.01% 3359
2022
Q1 		$4.7M Buy
40,402
+4,275
+12% +$499K ﹤0.01% 2308
2021
Q4 		$5.44M Buy
36,127
+3,929
+12% +$530K ﹤0.01% 2330
2021
Q3 		$3.84M Sell
32,198
-4,172
-11% -$460K ﹤0.01% 2516
2021
Q2 		$3.54M Sell
36,370
-12,910
-26% -$1.15M ﹤0.01% 2556
2021
Q1 		$4.35M Sell
49,280
-22,811
-32% -$2.12M ﹤0.01% 2346
2020
Q4 		$6.9M Buy
72,091
+23,118
+47% +$2.38M ﹤0.01% 1970
2020
Q3 		$5.56M Sell
48,973
-14,612
-23% -$1.54M ﹤0.01% 1935
2020
Q2 		$6.29M Buy
63,585
+3,198
+5% +$255K ﹤0.01% 1779
2020
Q1 		$3.88M Sell
60,387
-48,786
-45% -$3.42M ﹤0.01% 1994
2019
Q4 		$6.51M Sell
109,173
-88,533
-45% -$5.46M ﹤0.01% 1957
2019
Q3 		$11.7M Sell
197,706
-5,740
-3% -$366K ﹤0.01% 1456
2019
Q2 		$13.1M Buy
203,446
+66,851
+49% +$4.31M 0.01% 1367
2019
Q1 		$8.67M Sell
136,595
-64,970
-32% -$3.41M ﹤0.01% 1619
2018
Q4 		$7.65M Buy
201,565
+133,770
+197% +$4.72M ﹤0.01% 1687
2018
Q3 		$2.9M Buy
67,795
+8,683
+15% +$303K ﹤0.01% 2558
2018
Q2 		$1.3M Buy
59,112
+11,610
+24% +$143K ﹤0.01% 3033
2018
Q1 		$236K Buy
47,502
+47,500
+2,375,000% +$153K ﹤0.01% 4223
2017
Q4 		$0 Sell
2
-280
-99% -$879 ﹤0.01% 6884
2017
Q3 		$2K Sell
282
-748
-73% -$4.74K ﹤0.01% 6566
2017
Q2 		$8K Sell
1,030
-472
-31% -$4.36K ﹤0.01% 5890
2017
Q1 		$18K Buy
1,502
+811
+117% +$17.7K ﹤0.01% 5682
2016
Q4 		$14K Buy
691
+331
+92% +$12.7K ﹤0.01% 5953
2016
Q3 		$28K Sell
360
-56
-13% -$4.08K ﹤0.01% 5419
2016
Q2 		$31K Sell
416
-980
-70% -$78.9K ﹤0.01% 5318
2016
Q1 		$122K Buy
1,396
+454
+48% +$39.7K ﹤0.01% 4661
2015
Q4 		$111K Buy
942
+32
+4% +$3.17K ﹤0.01% 4878
2015
Q3 		$80K Sell
910
-15
-2% -$1.75K ﹤0.01% 4898
2015
Q2 		$100K Buy
925
+142
+18% +$17.7K ﹤0.01% 4834
2015
Q1 		$99K Buy
783
+93
+13% +$12.1K ﹤0.01% 4630
2014
Q4 		$87K Buy
690
+660
+2,200% +$91.5K ﹤0.01% 4798
2014
Q3 		$4K Hold
30
– – ﹤0.01% 5693
2014
Q2 		$5K Buy
+30
New +$5.11K ﹤0.01% 5571

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada's TNDM Position: Q1 2026 in Review

Royal Bank of Canada reduced its Tandem Diabetes Care (TNDM) stake by 1.2% in Q1 2026, selling an estimated $54.2K and leaving 206,033 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2594.

Royal Bank of Canada first reported a position in TNDM in Q2 2014 and has held it in 48 quarters since. The position peaked at $13.1M in Q2 2019. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Royal Bank of Canada held 206,033 shares of Tandem Diabetes Care worth $3.95M as of Q1 2026.
  • Royal Bank of Canada sold 2,495 Tandem Diabetes Care shares in Q1 2026, an estimated $54.2K.
  • Tandem Diabetes Care made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2594 holding.
  • Royal Bank of Canada first reported a position in Tandem Diabetes Care in Q2 2014 and has held it in 48 quarters since.
  • Royal Bank of Canada's Tandem Diabetes Care position peaked at $13.1M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.